Resumen
Significance: NAD + is an essential redox cofactor in cellular metabolism and has emerged as an important regulator of a wide spectrum of disease conditions, most notably, cancers. As such, various strategies targeting NAD + synthesis in cancers are in clinical trials. Recent Advances: Being a substrate required for the activity of various enzyme families, especially sirtuins and poly(adenosine diphosphate [ADP]-ribose) polymerases, NAD + -mediated signaling plays an important role in gene expression, calcium release, cell cycle progression, DNA repair, and cell proliferation. Many strategies exploring the potential of interfering with NAD + metabolism to sensitize cancer cells to achieve anticancer benefits are highly promising, and are being pursued. Critical Issues: With the multifaceted roles of NAD + in cancer, it is important to understand how cellular processes are reliant on NAD + . This review summarizes how NAD + metabolism regulates various pathophysiological processes in cancer, and how this knowledge can be exploited to devise effective anticancer therapies in clinical settings. Future Directions: In line with the redundant pathways that facilitate NAD + metabolism, further studies should comprehensively understand the roles of the various NAD + -synthesizing as well as NAD + -utilizing biomolecules to understand its true potential in cancer treatment.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 903-923 |
Número de páginas | 21 |
Publicación | Antioxidants and Redox Signaling |
Volumen | 30 |
N.º | 6 |
DOI | |
Estado | Published - 2019 |
Nota bibliográfica
Funding Information:This work was supported by grants from the Canadian Institute of Health Research (CIHR), from the Canadian Breast Cancer Foundation–Atlantic (CBCF), and Breast Cancer Society of Canada (BCSC)/QEII Foundation Awards for breast cancer research through Beatrice Hunter Cancer Research Institute (BHCRI) to S.A.G. and P.W.K.L. T.S. is supported by the CIHR. B.K. is supported through a postdoctoral fellowship from Cancer Research Training Program (CRTP) of BHCRI. C.D. is currently funded through CIHR Masters Award and Nova Scotia Health Research Foundation (NSHRF) Scotia Scholar Award. E.M. is supported by Nova Scotia Graduate Scholarship (NSGS) as well as NSHRF Scotia Scholar Award. E.M. and C.D. were recipients of the BHCRI studentship award in the past.
Publisher Copyright:
© Copyright 2019, Mary Ann Liebert, Inc., publishers 2019.
ASJC Scopus Subject Areas
- Physiology
- Biochemistry
- Molecular Biology
- Clinical Biochemistry
- Cell Biology